We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
Yes, I accept
Menu
Search Opener
Vienna, Austria

ESTRO 2023

Session

Biomarkers
Poster (Digital)
Clinical
MULTICENTE ASSESSMENT OF SNPs(HSPβ1) FOR HEMATOLOGICAL TOXICITY IN LUNG CANCER (HEMATOLUNG PROJECT)
Oscar Muñoz Muñoz, Spain
PO-1438
CIRT-induced cardiac biomarkers changes in patients with para/intra-cardiac tumours
Amelia Barcellini, Italy
PO-1439
Biomarker correlates of MC ROR1771: Prospective Proton SBRT and Nivolumab for Metastatic H&N Cancer
Daniel Ebner, USA
PO-1442
Could Blood tests have prognostic value in Glioma patients? A mono-institutional experience
Marco Lucarelli, Italy
PO-1443
Dynamic neutrophil-to-lymphocyte ratio - a new predictive biomarker for recurrent sarcomas?
Constanza Martinez, Canada
PO-1444
Pituitary transforming tumor gene (PTTG). A new biomarker for lung adenocarcinoma?
Oscar Muñoz Muñoz, Spain
PO-1445
Systematic Review of Prognostic and Predictive Biomarkers in HNSCC Treated with Radiotherapy
Daniel Schanne, Switzerland
PO-1446
Exploration of serum citrulline as a predictive biomarker for late bowel toxicity in prostate SABR.
Orla Houlihan, United Kingdom
PO-1447
Perfusion MRI and MRI spectroscopy: biomarkers of memory decline in pediatric brain tumor survivors
Fatima TENSAOUTI, France
PO-1448
Hsa-miR-3651 could serve as a novel predictor for in-breast recurrence via FRMD3
Elvis Ruznic, Austria
PO-1450
Neutrophil-lymphocyte ratio dynamics associated with survival after SBRT for stage I-II lung cancer
Sahar Shahamatdar, USA
PO-1451